Dendreon Corp
NASDAQ:DNDN
$14.05
-$0.73
(-4.94%)
Quote as of 3:59 PM EST on 02/10/12
|
$14.05
-$0.73
(-4.94%)
|
|
| Today's Open | $14.46 |
|---|---|
| Previous Close | $14.78 |
| Daily Range | $13.81 - $14.55 |
| 52-Week Range | $6.46 - $43.96 |
| Market Cap | $2.09B |
| P/E Ratio | -4.59 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 9,761,408 |
| Average Daily Volume | 13,021,456 |
| Current FY EPS | -$2.87 |
DNDN Information
| Description |
|---|
| A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
This Just In: More Upgrades and Downgrades
When Passing Your Clinical Trial Isn't Enough
Is Avanir Pharmaceuticals the Perfect Stock?
Can Amgen Convince Docs to Recommend Approval?
Minyanville's T3 Daily Recap: Market Quiet, but Stocks Moving -- What Does It Mean for the Rally?
This Just In: Upgrades and Downgrades
What's Going on With These Biotech Stocks?
Whoa! What Just Happened to My Stock?
Dendreon Gets a New CEO - Analyst Blog
New CEO = Dendreon Takeover Target?
